Botulinum Toxin for the Treatment of Depression
NCT00934687
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Depression
Interventions
DRUG:
clostridium botulinum toxin type A neurotoxin complex
OTHER:
0.9% NaCl solution
Sponsor
University Hospital, Basel, Switzerland
Collaborators
[object Object]